SlideShare a Scribd company logo
Preclinical Trials
What do you think?
• Have you ever had to take a medicine to treat an illness?
• Have you ever wondered how researchers determine if the
medicines you take are safe or not?
• Pre-Clinical Trials and Clinical Trials are the processes by which
scientists test drugs and devices to see if they are SAFE and EFFECTIVE.
What is a Preclinical Trial?
• Preclinical trial - a laboratory test of a new drug or a new medical
device, usually done on animal subjects, to see if the hoped-for
treatment really works and if it is safe to test on humans.
There are two types of Research: Basic and
Applied
Basic Research: discovering new facts about how
things work, how they are made, or what causes a
biological event to occur. Basic research can
explore a topic, explain a topic or describe a topic.
For Example: A researcher discovered that genes
can be turned off or on by small RNA molecules in
the body. This study was conducted on worms. It
led to the Nobel Prize in 2006.
“Basic” vs. “Applied”
Research
Applied Research: Taking the
information discovered in basic
research and investigating how to
use it to treat and prevent
sicknesses.
Example: A researcher uses the
information about turning genes
off and on to find a drug that is
used to turn off genes that cause
diseases and disorders in humans.
Segment of DNA.
Many such
segments act as
genes.
Where Do We Get New Ideas For Research?
Ideas come from all kinds of scientists and medical professionals who do
research in universities, government labs, and in corporations.
Take a Minute to Discuss:
• What is a Pre-Clinical Trial?
• What is the difference between basic research and applied
research?
• What sickness or disease would you like to see an effective
treatment for?
There are several steps involved with
doing a Pre-Clinical Trial:
File for approval as an Investigational New Drug
(IND)5
4
3
2
1
Establish Effective and Toxic Doses
Screen the Drug in the Assay
Develop a Bioassay
Indentify a Drug Target
Steps in Doing a
Pre-Clinical Trial:
• Drugs usually act on either cellular or genetic chemicals
in the body, known as targets,
which are believed to be associated with disease.
• Scientists use a variety of techniques to identify and
isolate individual targets to learn more about their
functions and how they influence disease.
• Compounds are then identified that have various
interactions with the drug targets that might be helpful
in treatment of a specific disease.
Step One: Get an idea for a
drug target.
Finding the Right Target Is Not Easy
Parkinson’sDiseaseExample:
Parkinson's disease:
a disease which causes
deterioration of the
central nervous system
over a period of time.
This disease often
impairs the patient’s
movement, speech, and
other functions.
• Tremors or shaking occurs when cells in one part of brain die. These cells
communicate using a chemical called dopamine.
• Drugs that replace dopamine work only for a few years.
• Other Parkinson’s symptoms (depression, sleep disorder, digestive problems,
loss of brain function) have other causes.
• Another sign of Parkinson’s disease: many cells have deposits of a protein,
synuclein.
• Four drug companies are developing drugs to counter synuclein, even
though nobody knows if it is a cause or a consequence of Parkinson’s.
• Synuclein could be like a tombstone—a marker, not a cause of cell death.
How is Parkinson’s treated? Where should the
focus be?
• Drugs target specific points in biochemical pathways
• Biochemical pathways are series of chemical reactions
occurring within a cell. In each pathway, a principal
chemical is modified by chemical reactions.
• Examples of different types of biochemical pathways:
A
E B
D C
A B C D E
Any step in the pathway, for
example from A to B, or B to C,
might be a target for the right
drug.
* See slide
note
Step Two: Developa Bioassay
A Bioassayis a “live”systemthat can be usedto
measuredrug effect.
• It may be a culture of cells or
organs or a whole animal.
For example:
• Zebra-fish embryos - you can
see effects of drugs on bone
density, blood vessel growth
and many other systems of the
zebra-fish.
Steps in Doing a
Pre-Clinical Trial:
• This is the actual test of the drug
on the chosen bioassay.
• This will determine if the drug is
SAFE and if it is EFFECTIVE in the
bioassay (BEFORE it is ever tested
on humans!)
Steps in Doing a
Pre-Clinical Trial:
Step Three: Screen the
drug in the Bioassay.
• Most drugs have a toxic level or an amount at which the
drug will become
harmful instead of helpful.
Steps in Doing a
Pre-Clinical Trial:
Step Four: Establish what dosage
amount of the drug is safe and what
dosage amount of the drug is toxic.
Toxicity study
• Acute toxicity- Acute toxicity studies are required
for all drugs these studies involve single
administration of the agent up to the lethal level
in at least two species. E.g. one rodent and one
nonrodent.
• Subacute & chronic toxicity- subacute and
chronic testing are required for most agents,
especially those intended for chronic use. Test s
are usually carried out for at least the amount of
time proposed for human application, i.e. 2-4
week (subacute) or 6-24 months (chronic),in at
least two species.
IND must show how the drug:
• Is manufactured.
• Appears (color, solubility, melting point,
particle size, moisture content).
• Formulated (pills, liquid, etc. + inactive ingredients).
• Will be analyzed for purity, concentration, stability.
• Will be tested for safety (this will be the basis for allowing
first use in humans).
Steps in Doing a
Pre-Clinical Trial:
Step Five: Application is made to the
Food and Drug Administration (FDA)
as an Investigational New Drug (IND).
Think Break:
• How are these steps like the steps of the Scientific Method?
• Why would research scientists use a Bioassay instead of a human
subject to test a new drug?
• What percentage of drugs do you think get this far in the process?
Review:StepstoNewDrug Discovery
Pre-ClinicalTrials
Get idea for drug target
Develop a bioassay
Screen chemical compounds in assay
Establish effective and toxic amounts
File for approval as an Investigational
New Drug (IND) (leads to clinical trials)
Can you summarize the process?
With a partner or your group, write a summary of
the Pre-Clinical Trial Process. Use the following
words to help you:
Drug
Safe
Effective
Basic Research
Applied Research
Target
Biochemical Pathway
Bioassay
Toxic
Investigational New Drug (IND)

More Related Content

What's hot

ICH GCP guidelines
ICH GCP guidelinesICH GCP guidelines
ICH GCP guidelines
rx_sonali
 
ICH-GCP Guidelines
ICH-GCP GuidelinesICH-GCP Guidelines
ICH-GCP Guidelines
Abel C. Mathew
 
Clinical trials
Clinical trialsClinical trials
Clinical trials
rasika walunj
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug Discovery
Suhas Reddy C
 
Drug development process.
Drug development process.Drug development process.
Drug development process.
Akhil Joseph
 
Phases in clinical trial
Phases in clinical trialPhases in clinical trial
Phases in clinical trial
Upendra Agarwal
 
Clinical drug development
Clinical drug developmentClinical drug development
Clinical drug development
Prof. Dr. Basavaraj Nanjwade
 
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
Aakashdeep Raval
 
Drug development process
Drug development processDrug development process
Drug development process
nasim arshadi
 
Clinical trials phases: Phase 0 to 4: An Overview
Clinical trials phases: Phase 0 to 4: An OverviewClinical trials phases: Phase 0 to 4: An Overview
Clinical trials phases: Phase 0 to 4: An Overview
Archana Gawade
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
Azeemsales
 
Main Responsibilities of a CRO Pharma
Main Responsibilities of a CRO PharmaMain Responsibilities of a CRO Pharma
Main Responsibilities of a CRO Pharma
Fomat Medical
 
Drug development process and clinical trial for UGs
Drug development process and clinical trial for UGsDrug development process and clinical trial for UGs
Drug development process and clinical trial for UGs
SameerKhasbage
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trials
DRx Tejas Kanhed
 
Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14
DR ANUP PETARE
 
Toxicological approach for drug discovery
Toxicological approach for drug discovery Toxicological approach for drug discovery
Toxicological approach for drug discovery
Dr Duggirala Mahendra
 
Drug development process
Drug development processDrug development process
Drug development process
PawanDhamala1
 
Clinical research
Clinical researchClinical research
Clinical research
DABBETA DIVYA
 
Pre Clinical Trials - Introduction
Pre Clinical Trials - Introduction Pre Clinical Trials - Introduction
Pre Clinical Trials - Introduction
Anbarasan Rajagopal
 

What's hot (20)

ICH GCP guidelines
ICH GCP guidelinesICH GCP guidelines
ICH GCP guidelines
 
Schedule y
Schedule ySchedule y
Schedule y
 
ICH-GCP Guidelines
ICH-GCP GuidelinesICH-GCP Guidelines
ICH-GCP Guidelines
 
Clinical trials
Clinical trialsClinical trials
Clinical trials
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug Discovery
 
Drug development process.
Drug development process.Drug development process.
Drug development process.
 
Phases in clinical trial
Phases in clinical trialPhases in clinical trial
Phases in clinical trial
 
Clinical drug development
Clinical drug developmentClinical drug development
Clinical drug development
 
Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.Preparation of Clinical Trial Protocol of India.
Preparation of Clinical Trial Protocol of India.
 
Drug development process
Drug development processDrug development process
Drug development process
 
Clinical trials phases: Phase 0 to 4: An Overview
Clinical trials phases: Phase 0 to 4: An OverviewClinical trials phases: Phase 0 to 4: An Overview
Clinical trials phases: Phase 0 to 4: An Overview
 
Preclinical studies
Preclinical studiesPreclinical studies
Preclinical studies
 
Main Responsibilities of a CRO Pharma
Main Responsibilities of a CRO PharmaMain Responsibilities of a CRO Pharma
Main Responsibilities of a CRO Pharma
 
Drug development process and clinical trial for UGs
Drug development process and clinical trial for UGsDrug development process and clinical trial for UGs
Drug development process and clinical trial for UGs
 
Roles and responsibilities in clinical trials
Roles and responsibilities in clinical trialsRoles and responsibilities in clinical trials
Roles and responsibilities in clinical trials
 
Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14Phases of clinical trial 11.9.14
Phases of clinical trial 11.9.14
 
Toxicological approach for drug discovery
Toxicological approach for drug discovery Toxicological approach for drug discovery
Toxicological approach for drug discovery
 
Drug development process
Drug development processDrug development process
Drug development process
 
Clinical research
Clinical researchClinical research
Clinical research
 
Pre Clinical Trials - Introduction
Pre Clinical Trials - Introduction Pre Clinical Trials - Introduction
Pre Clinical Trials - Introduction
 

Similar to Preclinical trials

Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.comDrug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.comNeelima Sharma
 
Drug development1.ppt
Drug development1.pptDrug development1.ppt
Drug development1.ppt
Priyanka Saroj
 
Bioinformatics in drug discovery
Bioinformatics in drug discoveryBioinformatics in drug discovery
Bioinformatics in drug discovery
KAUSHAL SAHU
 
New Drug Discovery And Development (part-2)
New Drug Discovery And Development (part-2)New Drug Discovery And Development (part-2)
New Drug Discovery And Development (part-2)
swatisejwani
 
History of clinical trials
History of clinical trialsHistory of clinical trials
History of clinical trialsUrmila Aswar
 
phases of a clinical trial and accelerated drug
 phases of a clinical trial and accelerated drug phases of a clinical trial and accelerated drug
phases of a clinical trial and accelerated drug
Sabeena Choudhary
 
Stages of drug development by Dr Joseph Oyepata Simeon (Ph.D)
Stages of drug development by Dr Joseph Oyepata Simeon (Ph.D)Stages of drug development by Dr Joseph Oyepata Simeon (Ph.D)
Stages of drug development by Dr Joseph Oyepata Simeon (Ph.D)
oyepata
 
1. An Overview of Drug Discovery Process.pdf
1. An Overview of Drug Discovery Process.pdf1. An Overview of Drug Discovery Process.pdf
1. An Overview of Drug Discovery Process.pdf
Yogeshwary Bhongade
 
Drug development process
Drug development process Drug development process
Drug development process
Zobayer Hossain
 
Drug discovery & development
Drug discovery & developmentDrug discovery & development
Drug discovery & development
Shubham Patil
 
Introduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsIntroduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugs
Kanthlal SK
 
Clinical trials
Clinical  trialsClinical  trials
Clinical trials
Nilesh Siddhawar
 
Covid- 19 Vaccines
Covid- 19 VaccinesCovid- 19 Vaccines
Covid- 19 Vaccines
SanjanaDey5
 
Drug Development Process
Drug Development ProcessDrug Development Process
Drug Development Process
INDERGOHRI
 
Preclinacal
PreclinacalPreclinacal
Preclinacal
VishalGalave2
 
Presentation (1)-1.pptx
Presentation (1)-1.pptxPresentation (1)-1.pptx
Presentation (1)-1.pptx
Jaibhagwan47
 
Introduction to drug discovery and development.pptx
Introduction to drug discovery and development.pptxIntroduction to drug discovery and development.pptx
Introduction to drug discovery and development.pptx
MingmaLhamuBhutia
 

Similar to Preclinical trials (20)

Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trials
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trials
 
Clinical Trials
Clinical TrialsClinical Trials
Clinical Trials
 
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.comDrug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
 
Drug development1.ppt
Drug development1.pptDrug development1.ppt
Drug development1.ppt
 
Bioinformatics in drug discovery
Bioinformatics in drug discoveryBioinformatics in drug discovery
Bioinformatics in drug discovery
 
New Drug Discovery And Development (part-2)
New Drug Discovery And Development (part-2)New Drug Discovery And Development (part-2)
New Drug Discovery And Development (part-2)
 
History of clinical trials
History of clinical trialsHistory of clinical trials
History of clinical trials
 
phases of a clinical trial and accelerated drug
 phases of a clinical trial and accelerated drug phases of a clinical trial and accelerated drug
phases of a clinical trial and accelerated drug
 
Stages of drug development by Dr Joseph Oyepata Simeon (Ph.D)
Stages of drug development by Dr Joseph Oyepata Simeon (Ph.D)Stages of drug development by Dr Joseph Oyepata Simeon (Ph.D)
Stages of drug development by Dr Joseph Oyepata Simeon (Ph.D)
 
1. An Overview of Drug Discovery Process.pdf
1. An Overview of Drug Discovery Process.pdf1. An Overview of Drug Discovery Process.pdf
1. An Overview of Drug Discovery Process.pdf
 
Drug development process
Drug development process Drug development process
Drug development process
 
Drug discovery & development
Drug discovery & developmentDrug discovery & development
Drug discovery & development
 
Introduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugsIntroduction to pre clinical screening of drugs
Introduction to pre clinical screening of drugs
 
Clinical trials
Clinical  trialsClinical  trials
Clinical trials
 
Covid- 19 Vaccines
Covid- 19 VaccinesCovid- 19 Vaccines
Covid- 19 Vaccines
 
Drug Development Process
Drug Development ProcessDrug Development Process
Drug Development Process
 
Preclinacal
PreclinacalPreclinacal
Preclinacal
 
Presentation (1)-1.pptx
Presentation (1)-1.pptxPresentation (1)-1.pptx
Presentation (1)-1.pptx
 
Introduction to drug discovery and development.pptx
Introduction to drug discovery and development.pptxIntroduction to drug discovery and development.pptx
Introduction to drug discovery and development.pptx
 

More from Suvarta Maru

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus
Suvarta Maru
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )
Suvarta Maru
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discovery
Suvarta Maru
 
USFDA & WHO
USFDA & WHOUSFDA & WHO
USFDA & WHO
Suvarta Maru
 
US FDA
US FDA US FDA
US FDA
Suvarta Maru
 
Toxicity slides
Toxicity slidesToxicity slides
Toxicity slides
Suvarta Maru
 
TGA & MHRA
TGA & MHRATGA & MHRA
TGA & MHRA
Suvarta Maru
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysis
Suvarta Maru
 
Stroke study
Stroke studyStroke study
Stroke study
Suvarta Maru
 
Schedules of drugs
Schedules of drugsSchedules of drugs
Schedules of drugs
Suvarta Maru
 
Schedule m
Schedule  m Schedule  m
Schedule m
Suvarta Maru
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
Suvarta Maru
 
Protein binding of drug
Protein binding of drugProtein binding of drug
Protein binding of drug
Suvarta Maru
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
Suvarta Maru
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDY
Suvarta Maru
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
Suvarta Maru
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
Suvarta Maru
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
Suvarta Maru
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
Suvarta Maru
 
New drug approval
New drug approvalNew drug approval
New drug approval
Suvarta Maru
 

More from Suvarta Maru (20)

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discovery
 
USFDA & WHO
USFDA & WHOUSFDA & WHO
USFDA & WHO
 
US FDA
US FDA US FDA
US FDA
 
Toxicity slides
Toxicity slidesToxicity slides
Toxicity slides
 
TGA & MHRA
TGA & MHRATGA & MHRA
TGA & MHRA
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysis
 
Stroke study
Stroke studyStroke study
Stroke study
 
Schedules of drugs
Schedules of drugsSchedules of drugs
Schedules of drugs
 
Schedule m
Schedule  m Schedule  m
Schedule m
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
 
Protein binding of drug
Protein binding of drugProtein binding of drug
Protein binding of drug
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDY
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
New drug approval
New drug approvalNew drug approval
New drug approval
 

Recently uploaded

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 

Recently uploaded (20)

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 

Preclinical trials

  • 2. What do you think? • Have you ever had to take a medicine to treat an illness? • Have you ever wondered how researchers determine if the medicines you take are safe or not?
  • 3. • Pre-Clinical Trials and Clinical Trials are the processes by which scientists test drugs and devices to see if they are SAFE and EFFECTIVE.
  • 4. What is a Preclinical Trial? • Preclinical trial - a laboratory test of a new drug or a new medical device, usually done on animal subjects, to see if the hoped-for treatment really works and if it is safe to test on humans.
  • 5. There are two types of Research: Basic and Applied Basic Research: discovering new facts about how things work, how they are made, or what causes a biological event to occur. Basic research can explore a topic, explain a topic or describe a topic. For Example: A researcher discovered that genes can be turned off or on by small RNA molecules in the body. This study was conducted on worms. It led to the Nobel Prize in 2006.
  • 6. “Basic” vs. “Applied” Research Applied Research: Taking the information discovered in basic research and investigating how to use it to treat and prevent sicknesses. Example: A researcher uses the information about turning genes off and on to find a drug that is used to turn off genes that cause diseases and disorders in humans. Segment of DNA. Many such segments act as genes.
  • 7. Where Do We Get New Ideas For Research? Ideas come from all kinds of scientists and medical professionals who do research in universities, government labs, and in corporations.
  • 8. Take a Minute to Discuss: • What is a Pre-Clinical Trial? • What is the difference between basic research and applied research? • What sickness or disease would you like to see an effective treatment for?
  • 9. There are several steps involved with doing a Pre-Clinical Trial: File for approval as an Investigational New Drug (IND)5 4 3 2 1 Establish Effective and Toxic Doses Screen the Drug in the Assay Develop a Bioassay Indentify a Drug Target
  • 10. Steps in Doing a Pre-Clinical Trial: • Drugs usually act on either cellular or genetic chemicals in the body, known as targets, which are believed to be associated with disease. • Scientists use a variety of techniques to identify and isolate individual targets to learn more about their functions and how they influence disease. • Compounds are then identified that have various interactions with the drug targets that might be helpful in treatment of a specific disease. Step One: Get an idea for a drug target.
  • 11. Finding the Right Target Is Not Easy Parkinson’sDiseaseExample: Parkinson's disease: a disease which causes deterioration of the central nervous system over a period of time. This disease often impairs the patient’s movement, speech, and other functions.
  • 12. • Tremors or shaking occurs when cells in one part of brain die. These cells communicate using a chemical called dopamine. • Drugs that replace dopamine work only for a few years. • Other Parkinson’s symptoms (depression, sleep disorder, digestive problems, loss of brain function) have other causes. • Another sign of Parkinson’s disease: many cells have deposits of a protein, synuclein. • Four drug companies are developing drugs to counter synuclein, even though nobody knows if it is a cause or a consequence of Parkinson’s. • Synuclein could be like a tombstone—a marker, not a cause of cell death. How is Parkinson’s treated? Where should the focus be?
  • 13. • Drugs target specific points in biochemical pathways • Biochemical pathways are series of chemical reactions occurring within a cell. In each pathway, a principal chemical is modified by chemical reactions. • Examples of different types of biochemical pathways: A E B D C A B C D E Any step in the pathway, for example from A to B, or B to C, might be a target for the right drug. * See slide note
  • 14. Step Two: Developa Bioassay A Bioassayis a “live”systemthat can be usedto measuredrug effect. • It may be a culture of cells or organs or a whole animal. For example: • Zebra-fish embryos - you can see effects of drugs on bone density, blood vessel growth and many other systems of the zebra-fish. Steps in Doing a Pre-Clinical Trial:
  • 15. • This is the actual test of the drug on the chosen bioassay. • This will determine if the drug is SAFE and if it is EFFECTIVE in the bioassay (BEFORE it is ever tested on humans!) Steps in Doing a Pre-Clinical Trial: Step Three: Screen the drug in the Bioassay.
  • 16. • Most drugs have a toxic level or an amount at which the drug will become harmful instead of helpful. Steps in Doing a Pre-Clinical Trial: Step Four: Establish what dosage amount of the drug is safe and what dosage amount of the drug is toxic.
  • 17. Toxicity study • Acute toxicity- Acute toxicity studies are required for all drugs these studies involve single administration of the agent up to the lethal level in at least two species. E.g. one rodent and one nonrodent. • Subacute & chronic toxicity- subacute and chronic testing are required for most agents, especially those intended for chronic use. Test s are usually carried out for at least the amount of time proposed for human application, i.e. 2-4 week (subacute) or 6-24 months (chronic),in at least two species.
  • 18. IND must show how the drug: • Is manufactured. • Appears (color, solubility, melting point, particle size, moisture content). • Formulated (pills, liquid, etc. + inactive ingredients). • Will be analyzed for purity, concentration, stability. • Will be tested for safety (this will be the basis for allowing first use in humans). Steps in Doing a Pre-Clinical Trial: Step Five: Application is made to the Food and Drug Administration (FDA) as an Investigational New Drug (IND).
  • 19. Think Break: • How are these steps like the steps of the Scientific Method? • Why would research scientists use a Bioassay instead of a human subject to test a new drug? • What percentage of drugs do you think get this far in the process?
  • 20. Review:StepstoNewDrug Discovery Pre-ClinicalTrials Get idea for drug target Develop a bioassay Screen chemical compounds in assay Establish effective and toxic amounts File for approval as an Investigational New Drug (IND) (leads to clinical trials)
  • 21. Can you summarize the process? With a partner or your group, write a summary of the Pre-Clinical Trial Process. Use the following words to help you: Drug Safe Effective Basic Research Applied Research Target Biochemical Pathway Bioassay Toxic Investigational New Drug (IND)